alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
```

[Congressional Bills 106th Congress]
[From the U.S. Government Publishing Office]
[H.R. 1460 Reported in Senate (RS)]

                                                       Calendar No. 912
106th CONGRESS
  2d Session
                                H. R. 1460

                          [Report No. 106-464]

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                           September 13, 2000

  Received; read twice and referred to the Committee on Indian Affairs

            October 2 (legislative day, September 22), 2000

              Reported by Mr. Campbell, without amendment

_______________________________________________________________________

                                 AN ACT

 
  To amend the Ysleta del Sur Pueblo and Alabama and Coushatta Indian 
Tribes of Texas Restoration Act to decrease the requisite blood quantum 
      required for membership in the Ysleta del Sur Pueblo tribe.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,
That section 108(a)(2)(i) of the Ysleta del Sur Pueblo and Alabama and 
Coushatta Indian Tribes of Texas Restoration Act (25 U.S.C. 1300g-7) is 
amended by striking ``\1/8\'' and inserting ``\1/16\''.

                                                       Calendar No. 912

106th CONGRESS

  2d Session

                               H. R. 1460

                          [Report No. 106-464]

_______________________________________________________________________

                                 A BILL

  To amend the Ysleta del Sur Pueblo and Alabama and Coushatta Indian 
Tribes of Texas Restoration Act to decrease the requisite blood quantum 
      required for membership in the Ysleta del Sur Pueblo tribe.

_______________________________________________________________________

            October 2 (legislative day, September 22), 2000

                       Reported without amendment
```
Henry Perry SIRECI, petitioner, v. FLORIDA.

No. 18-5040.

Supreme Court of the United States

Oct. 1, 2018.

Petition for writ of certiorari to the Supreme Court of Florida denied.
# Jornal Oficial C 18/2022

| | ISSN 1977-1010 |
| --- | --- |
| Jornal Oficial
  da União Europeia | C 18 |
| | |
| Edição em língua portuguesa | Comunicações e Informações | 65.° ano14 de janeiro de 2022 |

ISSN 1977-1010

Jornal Oficial

da União Europeia

C 18

Edição em língua portuguesa

Comunicações e Informações

65.° ano14 de janeiro de 2022

---

| Índice | Página |
| --- | --- |
| | IV   Informações |
| | INFORMAÇÕES DAS INSTITUIÇÕES, ÓRGÃOS E ORGANISMOS DA UNIÃO EUROPEIA |
| | Comissão Europeia |
| 2022/C 18/01 | Taxas de câmbio do euro — 13 de janeiro de 2022 | 1 |

Índice

Página

IV   Informações

INFORMAÇÕES DAS INSTITUIÇÕES, ÓRGÃOS E ORGANISMOS DA UNIÃO EUROPEIA

Comissão Europeia

2022/C 18/01

Taxas de câmbio do euro — 13 de janeiro de 2022

1

---

| PT | |
| --- | --- |

PT

---

IV Informações

INFORMAÇÕES DAS INSTITUIÇÕES, ÓRGÃOS E ORGANISMOS DA UNIÃO EUROPEIA

Comissão Europeia

| 14.1.2022 | PT | Jornal Oficial da União Europeia | C 18/1 |
| --- | --- | --- | --- |

14.1.2022

PT

Jornal Oficial da União Europeia

C 18/1

---

Taxas de câmbio do euro (1)

13 de janeiro de 2022

(2022/C 18/01)

1 euro =

| | Moeda | Taxas de câmbio |
| --- | --- | --- |
| USD | dólar dos Estados Unidos | 1,1463 |
| JPY | iene | 130,98 |
| DKK | coroa dinamarquesa | 7,4409 |
| GBP | libra esterlina | 0,83545 |
| SEK | coroa sueca | 10,2380 |
| CHF | franco suíço | 1,0453 |
| ISK | coroa islandesa | 147,00 |
| NOK | coroa norueguesa | 9,9333 |
| BGN | lev | 1,9558 |
| CZK | coroa checa | 24,458 |
| HUF | forint | 355,24 |
| PLN | zlóti | 4,5361 |
| RON | leu romeno | 4,9440 |
| TRY | lira turca | 15,5744 |
| AUD | dólar australiano | 1,5709 |
| CAD | dólar canadiano | 1,4304 |
| HKD | dólar de Hong Kong | 8,9289 |
| NZD | dólar neozelandês | 1,6676 |
| SGD | dólar singapurense | 1,5427 |
| KRW | won sul-coreano | 1 359,24 |
| ZAR | rand | 17,6381 |
| CNY | iuane | 7,2913 |
| HRK | kuna | 7,5202 |
| IDR | rupia indonésia | 16 379,02 |
| MYR | ringgit | 4,7875 |
| PHP | peso filipino | 58,572 |
| RUB | rublo | 86,6030 |
| THB | baht | 38,080 |
| BRL | real | 6,3518 |
| MXN | peso mexicano | 23,3894 |
| INR | rupia indiana | 84,7170 |

Moeda

Taxas de câmbio

USD

dólar dos Estados Unidos

1,1463

JPY

iene

130,98

DKK

coroa dinamarquesa

7,4409

GBP

libra esterlina

0,83545

SEK

coroa sueca

10,2380

CHF

franco suíço

1,0453

ISK

coroa islandesa

147,00

NOK

coroa norueguesa

9,9333

BGN

lev

1,9558

CZK

coroa checa

24,458

HUF

forint

355,24

PLN

zlóti

4,5361

RON

leu romeno

4,9440

TRY

lira turca

15,5744

AUD

dólar australiano

1,5709

CAD

dólar canadiano

1,4304

HKD

dólar de Hong Kong

8,9289

NZD

dólar neozelandês

1,6676

SGD

dólar singapurense

1,5427

KRW

won sul-coreano

1 359,24

ZAR

rand

17,6381

CNY

iuane

7,2913

HRK

kuna

7,5202

IDR

rupia indonésia

16 379,02

MYR

ringgit

4,7875

PHP

peso filipino

58,572

RUB

rublo

86,6030

THB

baht

38,080

BRL

real

6,3518

MXN

peso mexicano

23,3894

INR

rupia indiana

84,7170

---

(1)  Fonte: Taxas de câmbio de referência publicadas pelo Banco Central Europeu.

---
Dwayne STOUTAMIRE, petitioner, v. Christopher LA ROSE, Warden.

No. 18-7236.

Supreme Court of the United States

May 13, 2019.

Petition for rehearing denied.
BROOKDALE SENIOR LIVING COMMUNITIES, INC., et al., petitioners, v. UNITED STATES, ex rel. Marjorie PRATHER.

No. 18-699.

Supreme Court of the United States

March 18, 2019.

*1324Petition for writ of certiorari to the United States Court of Appeals for the Sixth Circuit denied.
<TABLE> <S> <C>


<ARTICLE> 5
<LEGEND>
The schedule contains summary financial information extracted from 1999 Broadway
Associates Limited Partnership and is qualified in its entirety by reference to
such financial statements.
</LEGEND>

<MULTIPLIER> 1

       

<S>                                                 <C>
<PERIOD-TYPE>                                       6-MOS
<FISCAL-YEAR-END>                                   DEC-31-1997
<PERIOD-START>                                      JAN-01-1997
<PERIOD-END>                                        JUN-30-1997
<CASH>                                                5,344,000   <F1>
<SECURITIES>                                                  0
<RECEIVABLES>                                                 0
<ALLOWANCES>                                                  0
<INVENTORY>                                                   0
<CURRENT-ASSETS>                                              0
<PP&E>                                               42,461,000
<DEPRECIATION>                                      (12,885,000)
<TOTAL-ASSETS>                                       37,248,000
<CURRENT-LIABILITIES>                                         0
<BONDS>                                              26,048,000
<COMMON>                                                      0
<PREFERRED-MANDATORY>                                         0
<PREFERRED>                                                   0
<OTHER-SE>                                            9,894,000
<TOTAL-LIABILITY-AND-EQUITY>                         37,248,000
<SALES>                                                       0
<TOTAL-REVENUES>                                      2,822,000
<CGS>                                                         0
<TOTAL-COSTS>                                         2,974,000
<OTHER-EXPENSES>                                              0
<LOSS-PROVISION>                                              0
<INTEREST-EXPENSE>                                    1,272,000
<INCOME-PRETAX>                                      (1,315,000)
<INCOME-TAX>                                                  0
<INCOME-CONTINUING>                                  (1,315,000)
<DISCONTINUED>                                                0
<EXTRAORDINARY>                                               0
<CHANGES>                                                     0
<NET-INCOME>                                         (1,315,000)
<EPS-PRIMARY>                                         (2,830.43)

<EPS-DILUTED>                                         (2,830.43)
<FN>
<F1> Includes $799,000 of restricted cash
</FN>
        


</TABLE>
```
  
 
VIX FUTURES - CBOE FUTURES EXCHANGE                                  Code-1170E1
OPTION AND FUTURES COMBINED POSITIONS AS OF 02/22/11          |
--------------------------------------------------------------| NONREPORTABLE
      NON-COMMERCIAL      |   COMMERCIAL    |      TOTAL      |   POSITIONS
--------------------------|-----------------|-----------------|-----------------
  Long  | Short  |Spreads |  Long  | Short  |  Long  | Short  |  Long  | Short
--------------------------------------------------------------------------------
($1000 X INDEX)                                      OPEN INTEREST:      162,587
COMMITMENTS
  15,556   26,658   34,377   90,503   84,481  140,436  145,516   22,151   17,071

CHANGES FROM 02/15/11 (CHANGE IN OPEN INTEREST:    -16,010)
  -6,392   -4,045   -4,433   -7,672  -12,413  -18,497  -20,891    2,487    4,881

PERCENT OF OPEN INTEREST FOR EACH CATEGORY OF TRADER
     9.6     16.4     21.1     55.7     52.0     86.4     89.5     13.6     10.5

NUMBER OF TRADERS IN EACH CATEGORY (TOTAL TRADERS:      101)
      30       27       36       27       30       81       81
```

----

Updated February 25, 2011
Tynisha Latrice REINERIO, nka Akosua Tanisha Aaebo, petitioner, v. BANK OF AMERICA, N.A., et al.

No. 18-8523.

Supreme Court of the United States

April 29, 2019.

Petition for writ of certiorari to the United States Court of Appeals for the Eighth Circuit denied.
Ian GOLDENBERG, et al., petitioners, v. TRANSCONTINENTAL GAS PIPE LINE COMPANY, LLC.

No. 18-1174.

Supreme Court of the United States

April 29, 2019.

Petition for writ of certiorari to the United States Court of Appeals for the Eleventh Circuit denied.
In Re Terrence Matthew BROWN, petitioner.

No. 18-5175.

Supreme Court of the United States

Oct. 1, 2018.

Motion of petitioner for leave to proceed *in forma pauperis* denied, and petition for writ of habeas corpus dismissed. See Rule 39.8.
# Fourth Court of Appeals

San Antonio, Texas

June 25, 2018

No. 04

- 18

- 00313

- CR

Jason Lee SALINAS,

Appellant

v.

The STATE of Texas,

Appellee

From the 365th Judicial District Court, Dimmit County, Texas

Trial Cou rt No. 14

- 08

- 02923

- DCRAJA

Honorable Amado J. Abascal, III, Judge Presiding



### O R D E R

The court reporter filed a notification of late record asking for additional time in which to

file the reporter’s record in this court. After review, we GRANT the requested extension and

ORDER the reporter to file the reporter’s record in this court on or before July 6, 2018.

_________________________________ Marialyn Barnard, Justice

IN WITNESS WHEREOF, I have hereunto set my hand and affixed the seal of the said

court on this 25th day of June, 2018

.

___________________________________ KEITH E. HOTTLE

, Clerk of Court
##### 



Exhibit 32




In connection with the Quarterly Report of Cole National Group, Inc. (the
Company) on Form 10-Q for the period ended May 1, 2004, as filed with the
Securities and Exchange Commission on the date hereof (the Report), each of
the undersigned officers of the Company certifies, pursuant to 18 U.S.C. §
1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that, to
such officers knowledge:



|(1) |  | The Report fully complies with the requirements of Section
13(a) or 15(d) of the Securities Exchange Act of 1934; and                                                                                           
|--- |  | ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|   
|(2) |  | The information contained in the Report fairly presents, in
all material respects, the financial condition and results of
operations of the Company as of the dates and for the periods
expressed in the Report.

Date: June 7, 2004/s/ Larry PollockName:
    
    Larry PollockTitle:
    
    President and Chief Executive Officer/s/ Lawrence E. HyattName:
    
    Lawrence E. HyattTitle:
    
    Chief Financial Officer


The foregoing certification is being furnished solely pursuant to 18
U.S.C. § 1350 and is not being filed as part of the Report or as a separate
disclosure document.
Document headings vary by document type but may contain
                    the following: the agency or agencies that issued and signed a document
the number of the CFR title and the number of each part
                      the document amends, proposes to amend, or is directly
                      related to
the agency docket number / agency internal file number
the RIN which identifies each regulatory action listed in
                      the Unified Agenda of Federal Regulatory and Deregulatory
                      Actions See the
                    Document Drafting Handbook
                    for more details.
 Department of Justice Drug Enforcement Administration [Docket No. DEA-991]
 AGENCY: Drug Enforcement Administration, Justice.
 ACTION: Notice of application.
 SUMMARY: Patheon Pharmaceuticals Inc. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to 
                        **SUPPLEMENTAL INFORMATION**
                         listed below for further drug information.
 DATES: Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may submit electronic comments on or objections to the issuance of the proposed registration on or before July 5, 2022. Such persons may also file a written request for a hearing on the application on or before July 5, 2022.
 ADDRESSES: The Drug Enforcement Administration requires that all comments be submitted electronically through the Federal eRulemaking Portal, which provides the ability to type short comments directly into the comment field on the web page or attach a file for lengthier comments. Please go to 
                        *https://www.regulations.gov*
                         and follow the online instructions at that site for submitting comments. Upon submission of your comment, you will receive a Comment Tracking Number. Please be aware that submitted comments are not instantaneously available for public view on 
                        *https://www.regulations.gov.*
                         If you have received a Comment Tracking Number, your comment has been successfully submitted and there is no need to resubmit the same comment.”


SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this is notice that on February 3, 2022, Patheon Pharmaceuticals Inc., 2110 East Galbraith Road, Cincinnati, Ohio 45237-1625, applied to be registered as a bulk manufacturer of the following basic class(es) of controlled substance(s): Controlled substance
Drug code
ScheduleGamma Hydroxybutyric Acid
2010
I
 The company plans to manufacture the above-listed controlled substance as Active Pharmaceutical Ingredient (API) that will be further synthesized into Food and Drug Administration-approved dosage forms. No other activities for this drug code are authorized for this registration. Matthew J. Strait, Deputy Assistant Administrator.


[FR Doc. 2022-09779 Filed 5-5-22; 8:45 am] BILLING CODE P
Jesus M. RIOS-RAMOS, petitioner, v. UNITED STATES.

No. 18-5245.

Supreme Court of the United States

Oct. 1, 2018.

Petition for writ of certiorari to the United States Court of Appeals for the First Circuit denied.
Bryan Frederick JENNINGS, petitioner, v. FLORIDA.

No. 18-8323.

Supreme Court of the United States

May 13, 2019.

*2020Petition for writ of certiorari to the Supreme Court of Florida denied.
Jose VILLANUEVA-CARDENAS, petitioner, v. UNITED STATES.

No. 18-5317.

Supreme Court of the United States

Oct. 1, 2018.

Petition for writ of certiorari to the United States Court of Appeals for the Fifth Circuit denied.
``

# CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER
PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF
THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual
Report on Form 10-KSB of New Tech Resources, Ltd. (Registrant) for the annual
period ended August 31, 2003 as filed with the Securities and Exchange Commission on
the date hereof (Report), I, Ross Wilmot, chief executive officer and
chief financial officer, hereby certify, pursuant to 18 U.S.C. §1350, as adopted
pursuant to §906 of the Sarbanes-Oxley Act of 2002, that, to the best of my
knowledge:

|(1) | This Report complies with the requirements of section 13(a) or 15(d) of the
          Securities Exchange Act of 1934; and
|--- | --------------------------------------------------------------------------------------------------------------------------

|(2) | The information contained in this Report fairly represents, in all material
          respects, the financial condition of Registrant at the end of the period covered
          by this Report and results of operations of Registrant for the period covered by
          this Report.
|--- | ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

/s/ Ross Wilmot

Ross Wilmot

Chief Executive Officer
and Chief Financial Officer

This certification accompanies this
Report pursuant to §906 of the Sarbanes-Oxley Act of 2002 and shall not, except to
the extent required by the Sarbanes-Oxley Act of 2002, be deemed filed by Registrant for
the purposes of §18 of the Securities Exchange Act of 1934, as amended. This
certification shall not be incorporated by reference into any filing under the Securities
Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended (whether made
before or after the date of this Report), irrespective of any general incorporation
language contained in such filing.

A signed original of this written
statement required by §906 has been provided to the Registrant and will be retained
by the Registrant and furnished to the Securities and Exchange Commission or its staff
upon request.
Exhibit 32.2

CERTIFICATION OF CHIEF FINANCIAL OFFICER

PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED
PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

I, Omer Regev, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my
knowledge, the Quarterly Report on Form 10-Q of NetManage, the Periodic Report, for the period ended March 31, 2007 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that the
information contained in such Periodic Report fairly presents, in all material respects, the financial condition of the Company at the end of the period covered by the Periodic Report and results of operations of the Company for the period covered
by the Periodic Report.



By:

/s/ Omer RegevName:

Omer RegevTitle:

Chief Financial Officer and Vice President of FinanceDated:

May 21, 2007
Exhibit 31.2



Section 302 Certification
(Hamon Francis Fytton)



I, Hamon Francis Fytton, certify
that:



1. I have reviewed this
Form 10-KSB of Gold Entertainment Group, Inc.:



2. Based on my knowledge,
this report does not contain any untrue statement of a material fact
or omit to state a material fact necessary to make the statements
made, in light of the circumstances under which such statements were
made, not misleading with respect to the period covered by this
report;



3. Based on my knowledge,
the financial statements, and other financial information included in
this report, fairly present in all material respects the financial
condition, results of operations and cash flows of the registrant as
of, and for, the periods presented in this report;



4. The registrant's other
certifying officers and I are responsible for establishing and
maintaining disclosure controls and procedures (as defined in
Exchange Act Rules 13a-15(e) and 15d-15(e) for the registrant and
have:



a) Designed such
disclosure controls and procedures, or caused such disclosure
controls and procedures to be designed under our supervision, to
ensure that material information relating to the registrant,
including its consolidated subsidiaries, is made known to us by
others within those entities, particularly during the period in which
this report is being prepared;



b) Evaluated the
effectiveness of the registrant's disclosure controls and procedures
and presented in this report our conclusions about the effectiveness
of the disclosure controls and procedures, as of the end of the
period covered by this report based on such evaluation; and



c) Disclosed in this
report any change in the registrant's internal control over
financial reporting that occurred during the registrant's most
recent fiscal quarter (the registrant's fourth fiscal quarter in
the case of an annual report) that has materially affected, or is
reasonably likely to materially affect, the registrant's internal
control over financial reporting; and



5. The registrant's other
certifying officer (s) and I have disclosed, based on our most recent
evaluation of internal controls over financial reporting, to the
registrant's auditors and the audit committee of registrant's board
of directors (or persons performing the equivalent functions):



a) All significant
deficiencies and material weaknesses in the design or operation of
internal controls over financial reporting which are reasonably
likely to adversely affect the registrant's ability to record,
process, summarize and report financial information; and

b) Any fraud, whether or
	not material, that involves management or other employees who have a
	significant role in the registrant's internal control over financial
	reporting.

Prepared and Signed

Date: December 21, 2004



By:/s/
Hamon Francis Fytton

Hamon Francis Fytton

Chief Financial Officer



(Principal Financial
Officer)
EXHIBIT 14.3







CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM



We consent to the incorporation by reference
  in the Registration Statements on Form S-8 (Nos. 333-13178, 333-14224, 333-119938,
  333-124241, 333-130657 and 333-137680) of our report dated March 24, 2006 (except
  for the note 40 for which the date is May 10, 2006) with respect to the consolidated
  financial statements of Thomson included in its amended Annual Report (Form
  20-F/A) for the year ended December 31, 2006, filed with the Securities and
  Exchange Commission.







|BARBIER
        FRINAULT & AUTRES
      ERNST
        & YOUNG
      Jérôme Guirauden
|------------------------------------------------------------------------------------









Paris-La Défense and Neuilly-sur-Seine, France

July 24, 2007